Clinical Trial Update: Comparative Registry of the PROmus™, ENdeavor™ and CYpher™ Drug Eluting Stents

View source ↗

Summary

A completed registry study comparing Promus, Endeavor, and Cypher drug-eluting stents used in percutaneous coronary intervention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cypher (sirolimus-eluting coronary stent)
• Endeavor (Paclitaxel)
• Promus (sirolimus-eluting stent)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Percutaneous Coronary Intervention | Status: COMPLETED